These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 14085746)
1. [SENSITIZATION IN PREGNANCY WITH THE KELL GROUP FACTOR AND THE DISTRIBUTION OF THIS FACTOR]. UMNOVA MA; PISKUNOVA TM; ICHALOVSKAIA TA Akush Ginekol (Mosk); 1963; 39():79-82. PubMed ID: 14085746 [No Abstract] [Full Text] [Related]
2. ERYTHROBLASTOSIS FETALIS DUE TO SENSITIZATION TO KELL FACTOR: REPORT OF A CASE. CROUCH FR Mo Med; 1964 Nov; 61():930-1. PubMed ID: 14221282 [No Abstract] [Full Text] [Related]
3. The significance of anti-Kell sensitization in pregnancy. Mayne KM; Bowell PJ; Pratt GA Clin Lab Haematol; 1990; 12(4):379-85. PubMed ID: 2081378 [TBL] [Abstract][Full Text] [Related]
4. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management. Wenk RE; Goldstein P; Felix JK Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011 [TBL] [Abstract][Full Text] [Related]
5. [Status of Kell incompatibility in a 15-year retrospective study of mother-child serology in clinical records]. Schönitzer D Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():3-9. PubMed ID: 3596796 [TBL] [Abstract][Full Text] [Related]
6. Erythroblastosis fetalis with hydrops resulting from anti-Kell isoimmune disease. Frigoletto FD; Davies IJ Am J Obstet Gynecol; 1977 Apr; 127(8):887. PubMed ID: 851149 [No Abstract] [Full Text] [Related]
7. [A clinical case of pregnancy isoimmunization caused by the Kell system]. Orsini G; Serratì A; Schonauer S; Cramarossa D Minerva Ginecol; 1977 Oct; 29(10):727-30. PubMed ID: 593610 [No Abstract] [Full Text] [Related]
8. [Serologic incompatibility and family planning]. Matýsek P; Ungerová A; Cuprová M; Muchová M Cesk Gynekol; 1988 Aug; 53(7):497-9. PubMed ID: 3168017 [No Abstract] [Full Text] [Related]
9. [Sensitization caused by rare antigens and hemolytic disease of the newborn]. Moretti M; Bovi I; Bevilacqua G Minerva Pediatr; 1968 Sep; 20(37):1923-5. PubMed ID: 5754687 [No Abstract] [Full Text] [Related]
13. [Fetal erythroblastosis in Kell incompatibility]. Fuith LC; Bichler A; Schönitzer D Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):131-3. PubMed ID: 3471624 [TBL] [Abstract][Full Text] [Related]
14. [Irregular blood group antibodies during pregnancy: screening is mandatory]. Semmekrot BA; de Man AJ; Boekkooi PF; van Dijk BA Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1449-52. PubMed ID: 10443258 [TBL] [Abstract][Full Text] [Related]
15. Non-Rh0 (D) hemolytic disease of the newborn: an obstetric viewpoint. Zlatnik FJ Semin Perinatol; 1977 Apr; 1(2):169-75. PubMed ID: 754292 [No Abstract] [Full Text] [Related]
16. Chorionic biopsy in management of severe Kell alloimmunization. Rodesch F; Lambermont M; Donner C; Simon P; Romasco F; Schwers J; Wybran J Am J Obstet Gynecol; 1987 Jan; 156(1):124-5. PubMed ID: 3799745 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940 [TBL] [Abstract][Full Text] [Related]
18. [Perinatal research on feto-maternal anti-Kell immunization]. Gavriil P; Jauniaux E; Lambermont M; Donner C; Avni FE; Rodesch F J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):761-4. PubMed ID: 2689503 [TBL] [Abstract][Full Text] [Related]
19. Current clinical concepts in hemolytic disease and blood group incompatibility. Cherry SH Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933 [No Abstract] [Full Text] [Related]
20. Erythroblastosis fetalis produced by Kell immunization: dental findings. Cullen CL Pediatr Dent; 1990; 12(6):393-6. PubMed ID: 2087415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]